<DOC>
	<DOC>NCT00759148</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of Moxifloxacin AF Ophthalmic Solution compared to Moxifloxacin AF Vehicle in the treatment of bacterial conjunctivitis in patients one month of age or older.</brief_summary>
	<brief_title>Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Bacterial</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>Signs and symptoms of bacterial conjunctivitis in one or both eyes Under 1 month in age</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>pink eye</keyword>
	<keyword>conjunctivitis</keyword>
	<keyword>moxifloxacin</keyword>
	<keyword>fluoroquinolone</keyword>
</DOC>